The Condition Nobody Studied

The front of this bottle carries two claims, and one of them is checkable. It reads “Clinically Studied Ingredients†” — and that sentence is true. Three of the ten ingredients on this panel carry named clinical trials in the material supplied to this desk: alpha lipoic acid, benfotiamine and acetyl L-carnitine.

So this post audits the claim rather than disputing it, and the audit produces two findings that have to be carried together. All three trials used more than this label prints. And all three were carried out in diabetic neuropathy, which is nerve damage from high blood sugar. MedlinePlus on the condition this product is named after: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.” Pressure on a nerve is mechanical; diabetic polyneuropathy is metabolic.

No trial cited anywhere on this site was carried out in sciatica. That sentence is the whole of the post, and the rest is the working behind it.

The third row is the widest gap on the panel, by a factor of thirty, and it is also the row where the research itself is least certain — which makes it the most important of the three.

Acetyl L-carnitine is printed at 50 mg. A Cochrane review examined four trials and about 906 participants with diabetic peripheral neuropathy, at 1,500 mg, 2,000 mg and 3,000 mg a day. Its plain-language conclusion, word for word: “We are uncertain whether ALC reduces pain in DPN, as the evidence is sparse and of very low certainty.”

Hold both halves of that at once. The printed amount is one thirtieth of the lowest dose used in those trials — 1,500 divided by 50 is 30 — and the trials were in diabetic peripheral neuropathy rather than in sciatica. And even at thirty times this amount, in the condition that was actually studied, the review’s own verdict is uncertainty, with the evidence described as sparse and of very low certainty.

This is the row where the printed-amount discipline of the panel does the most work. Inside a pooled total, nobody outside the factory could have told you whether this row was 50 mg or 500 mg. Here it is printed, so the comparison is a division anyone can do.

Three things this post is not saying, and they matter as much as the three it is.

It is not saying the ingredients are useless. An ingredient studied in one nerve condition is not thereby useless in another; it is untested there, and untested is the accurate word. Nothing above is evidence against these ingredients in sciatica, because evidence against would require a trial too.

It is not saying the label lied. The front of the bottle says “Clinically Studied Ingredients†” It does not say studied in sciatica, and it would not be true if it did. The claim as written is accurate about three rows out of ten, and the required disclaimer is printed on the back.

And it is not saying a smaller amount cannot matter. Dose-response is not always linear, and nobody has tested these three ingredients at these amounts in this condition. There is no trial of this formula either, so no timeline for this product exists: what is actually knowable is set out on the results timeline page.

So what would change this page? A trial of these ingredients, at these amounts, in people with sciatica. That trial would be reported here on the day it appeared. Short of it, the federal instruction is the one to hold: MedlinePlus says “Treatment, if needed, depends on the cause of the problem. It may include exercises, medicines, and surgery.” And on the course of the thing, in both directions: “In many cases no cause can be found.” and “Sometimes sciatica goes away on its own.” Read those together and the oldest mistake in self-care becomes obvious — improvement without treatment happens, and attributing it to the last thing you started is not evidence.

If what you have is a symptom rather than a shopping question, the symptoms that mean contact a provider right away are printed in full on the sciatica page. And six of the ten rows here have no federal consumer page at all, so the panel goes to a pharmacist rather than a search engine — particularly if you take anything for blood sugar, since every trial above was run in people who did.